"10.1371_journal.pone.0045539","plos one","2012-10-08T00:00:00Z","Kelly Coffey; Timothy J Blackburn; Susan Cook; Bernard T Golding; Roger J Griffin; Ian R Hardcastle; Lorraine Hewitt; Kety Huberman; Hesta V McNeill; David R Newell; Celine Roche; Claudia A Ryan-Munden; Anna Watson; Craig N Robson","Solid Tumour Target Discovery Laboratory, Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United Kingdom; Drug Discovery and Imaging Group, Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United Kingdom; OSI Pharmaceuticals, Inc, Farmingdale, New York, United States of America; Research and School of Chemistry, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United Kingdom","Conceived and designed the experiments: KC IRH RJG BTG CNR. Performed the experiments: LH HVM SC KC TJB BTG RJG IRH KH CR AW DRN CARM. Analyzed the data: KC CNR. Wrote the paper: KC TJB BTG RJG IRH DRN CNR KC.","KH was employed by OSI Pharmaceuticals, Inc. Compounds discussed in this article are not patented, in development or being marketed by this company. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Kelly Coffey","KC",14,TRUE,5,13,2,7,TRUE,TRUE,FALSE,0,NA,FALSE
